Muscle Hypotonia in Lowe’s Syndrome
As part of a comprehensive evaluation of 23 patients with the oculocerebrorenal syndrome of Lowe at the Section on Human Biochemical Genetics, National Institutes of Health, Bethesda, MD, concentrations of muscle enzymes and carnitine metabolism were studied in addition to special reference to growt...
| Published in: | Pediatric Neurology Briefs |
|---|---|
| Main Author: | J Gordon Millichap |
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1991-06-01
|
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/3188 |
Similar Items
Novel mutation in OCRL leading to a severe form of Lowe syndrome
by: Feng-Qi Zhou, et al.
Published: (2019-07-01)
by: Feng-Qi Zhou, et al.
Published: (2019-07-01)
Aspecte eiopatogenetice, manifestări clinice și particularități de tratament ale sindromului oculocerebrorenal. Prezentare de caz clinic
by: Svetlana Hadjiu, et al.
Published: (2020-10-01)
by: Svetlana Hadjiu, et al.
Published: (2020-10-01)
Lowe Syndrome and Me: a co-creation video series connecting patients, caregivers, and researchers
by: Theresa Haugen, et al.
Published: (2025-06-01)
by: Theresa Haugen, et al.
Published: (2025-06-01)
Síndrome de Lowe: relato de cinco casos Lowe syndrome: report of five cases
by: Marta Liliane de Almeida Maia, et al.
Published: (2010-06-01)
by: Marta Liliane de Almeida Maia, et al.
Published: (2010-06-01)
Carnitine Deficiency Syndromes
by: J Gordon Millichap
Published: (1996-01-01)
by: J Gordon Millichap
Published: (1996-01-01)
Valproate, Carnitine, and Lipid Metabolism
by: J Gordon Millichap
Published: (1990-06-01)
by: J Gordon Millichap
Published: (1990-06-01)
Prognosis of Benign Congenital Hypotonia
by: J Gordon Millichap
Published: (1998-09-01)
by: J Gordon Millichap
Published: (1998-09-01)
Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
by: Chi-Jen Lo, et al.
Published: (2023-11-01)
by: Chi-Jen Lo, et al.
Published: (2023-11-01)
Valproic Acid and Carnitine Metabolism
by: J Gordon Millichap
Published: (1991-11-01)
by: J Gordon Millichap
Published: (1991-11-01)
ROLE AND LOCATION OF L-CARNITINE IN CYTOPROTECTION AND CORRECTION OF METABOLIC PROCESSES IN PATIENTS WITH METABOLIC SYNDROME
by: D. I. Trukhan
Published: (2017-11-01)
by: D. I. Trukhan
Published: (2017-11-01)
Clofazimine-Mediated, Age-Related Changes in Skeletal Muscle Mitochondrial Metabolites
by: Jennifer Diaz-Espinosa, et al.
Published: (2023-05-01)
by: Jennifer Diaz-Espinosa, et al.
Published: (2023-05-01)
Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
by: Anna Suzuki, et al.
Published: (2018-10-01)
by: Anna Suzuki, et al.
Published: (2018-10-01)
Plasma TMAO Concentrations and Gut Microbiota Composition in Subjects with and Without Metabolic Syndrome: Results from Pilot Study
by: Mohammed E. Hefni, et al.
Published: (2025-05-01)
by: Mohammed E. Hefni, et al.
Published: (2025-05-01)
Efficiency of L-arginine and L-carnitine in the Complex Treatment of Patients With Acute Myocardial Infarction and Comorbid Metabolic Syndrome
by: Shved M., et al.
Published: (2018-12-01)
by: Shved M., et al.
Published: (2018-12-01)
Rational Design, Synthesis, and In Vitro Activity of Heterocyclic Gamma-Butyrobetaines as Potential Carnitine Acetyltransferase Inhibitors
by: Savina Stoyanova, et al.
Published: (2025-02-01)
by: Savina Stoyanova, et al.
Published: (2025-02-01)
Effects of Dietary L-carnitine Supplementation on Growth Performance, Organ Weight, Biochemical Parameters and Ascites Susceptibility in Broilers Reared Under Low-temperature Environment
by: Y. W. Wang, et al.
Published: (2013-02-01)
by: Y. W. Wang, et al.
Published: (2013-02-01)
Is hyperammonemia helpful in detecting syndromic tubulopathies with early extrarenal manifestations? A case report of Lowe’s syndrome
by: Agnieszka Jędzura, et al.
Published: (2024-08-01)
by: Agnieszka Jędzura, et al.
Published: (2024-08-01)
Mitochondrial Myopathy and Hypotonia
by: J Gordon Millichap
Published: (1992-05-01)
by: J Gordon Millichap
Published: (1992-05-01)
Rational Design, Synthesis and In Vitro Activity of Diastereomeric <i>Cis</i>-/<i>Trans</i>-3-Substituted-3,4-Dihydroisocoumarin-4-Carboxylic Acids as Potential Carnitine Acetyltransferase Inhibitors
by: Savina Stoyanova, et al.
Published: (2025-07-01)
by: Savina Stoyanova, et al.
Published: (2025-07-01)
Unfavorable Associations Between Serum Trimethylamine N-Oxide and L-Carnitine Levels With Components of Metabolic Syndrome in the Newfoundland Population
by: Xiang Gao, et al.
Published: (2019-03-01)
by: Xiang Gao, et al.
Published: (2019-03-01)
Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets
by: J. Keller, et al.
Published: (2012-01-01)
by: J. Keller, et al.
Published: (2012-01-01)
Research Progress on the Effects and Mechanisms of L-carnitine on Improving Metabolic Syndrome
by: Chengyuan SUN, et al.
Published: (2023-01-01)
by: Chengyuan SUN, et al.
Published: (2023-01-01)
Pelizaeus-Merzbacher Disease and Hypotonia
by: J Gordon Millichap
Published: (1995-02-01)
by: J Gordon Millichap
Published: (1995-02-01)
Diagnostic Approach to Neonatal Hypotonia
by: J Gordon Millichap
Published: (2008-04-01)
by: J Gordon Millichap
Published: (2008-04-01)
Association of Low Muscle Mass and Isokinetic Strength with Metabolic Syndrome
by: Hoyoun Kim, et al.
Published: (2020-06-01)
by: Hoyoun Kim, et al.
Published: (2020-06-01)
Effect of L-carnitine supplementation on muscle cramps in liver cirrhosis: results from a retrospective cohort study
by: Gholam Reza Sivandzadeh, et al.
Published: (2025-03-01)
by: Gholam Reza Sivandzadeh, et al.
Published: (2025-03-01)
Carnitine in Valproate-Induced Hyperammonemia
by: J Gordon Millichap
Published: (1996-06-01)
by: J Gordon Millichap
Published: (1996-06-01)
Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel DiseaseSummary
by: Johanna M.S. Lemons, et al.
Published: (2024-01-01)
by: Johanna M.S. Lemons, et al.
Published: (2024-01-01)
Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
by: Feng Xiang, et al.
Published: (2025-03-01)
by: Feng Xiang, et al.
Published: (2025-03-01)
Lipid storage myopathy with clinical markers of Marfan syndrome: A rare association
by: Subasree Ramakrishnan, et al.
Published: (2012-01-01)
by: Subasree Ramakrishnan, et al.
Published: (2012-01-01)
Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency
by: Oliver P. Hanington, et al.
Published: (2023-11-01)
by: Oliver P. Hanington, et al.
Published: (2023-11-01)
Assessment of the Preventive Effect of L-carnitine on Post-statin Muscle Damage in a Zebrafish Model
by: Joanna Niedbalska-Tarnowska, et al.
Published: (2022-04-01)
by: Joanna Niedbalska-Tarnowska, et al.
Published: (2022-04-01)
Muscle mass rather than muscle strength or physical performance is associated with metabolic syndrome in community-dwelling older Chinese adults
by: Peiyu Song, et al.
Published: (2021-03-01)
by: Peiyu Song, et al.
Published: (2021-03-01)
Carnitine PT II Deficiency and Cerebral Dysgenesis
by: J Gordon Millichap
Published: (1995-10-01)
by: J Gordon Millichap
Published: (1995-10-01)
Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis
by: Mohd Falihin Mohd Shukri, et al.
Published: (2022-09-01)
by: Mohd Falihin Mohd Shukri, et al.
Published: (2022-09-01)
Sarcopenia (defined by low muscle mass) as a predictor of disease progression and mortality in cardiovascular-kidney-metabolic syndrome
by: Diar Zooravar
Published: (2025-10-01)
by: Diar Zooravar
Published: (2025-10-01)
Effect of L-Carnitine on Muscle Quality and Antioxidant Capacity of Hybrid Sheep at an Early Stage
by: Xia Qin, et al.
Published: (2025-08-01)
by: Xia Qin, et al.
Published: (2025-08-01)
Successful treatment of propofol-related infusion syndrome in critically ill patient receiving low-dose propofol infusion: a case report
by: Nahyeon Park, et al.
Published: (2023-02-01)
by: Nahyeon Park, et al.
Published: (2023-02-01)
The Mitochondrial Carnitine Acyl-carnitine Carrier (SLC25A20): Molecular Mechanisms of Transport, Role in Redox Sensing and Interaction with Drugs
by: Annamaria Tonazzi, et al.
Published: (2021-03-01)
by: Annamaria Tonazzi, et al.
Published: (2021-03-01)
L-carnitine prevents lenvatinib-induced muscle toxicity without impairment of the anti-angiogenic efficacy
by: Zheng Jing, et al.
Published: (2023-04-01)
by: Zheng Jing, et al.
Published: (2023-04-01)
Similar Items
-
Novel mutation in OCRL leading to a severe form of Lowe syndrome
by: Feng-Qi Zhou, et al.
Published: (2019-07-01) -
Aspecte eiopatogenetice, manifestări clinice și particularități de tratament ale sindromului oculocerebrorenal. Prezentare de caz clinic
by: Svetlana Hadjiu, et al.
Published: (2020-10-01) -
Lowe Syndrome and Me: a co-creation video series connecting patients, caregivers, and researchers
by: Theresa Haugen, et al.
Published: (2025-06-01) -
Síndrome de Lowe: relato de cinco casos Lowe syndrome: report of five cases
by: Marta Liliane de Almeida Maia, et al.
Published: (2010-06-01) -
Carnitine Deficiency Syndromes
by: J Gordon Millichap
Published: (1996-01-01)
